Neither is universally "better." The right choice depends on your priorities, medical history, and practical circumstances
According to statistics mentioned by Zealand, although two approved once-weekly GLP-1 receptor agonists (semaglutide and tirzepatide) have been authorized for treating obesity and can achieve a weight reduction of approximately 15-21%, up to 30% of obese patients discontinue the treatment within the first month of starting a GLP-1 receptor agonist (GLP-1RA) therapy
Bodybuilding.com Signature L-Carnitine Pro Supps L-Carnitine 3000 SNAP Supplements L-Carnitine Gummies Forzagen Premium L Carnitine + CLA + Raspberry Ketones Stim-Free Codeage Acetyl L-Carnitine+ Enhanced Absorption Supplement Codeage L-Carnitine+ Free-Form Amino Acid Supplement Pro Supps L-Carnitine 1500 Prolab Nutrition L-Carnitine Musclesport L-Carnitine Revolution Your Cart is Empty
You should contact your GP if you experience : Unexplained weight gain , particularly affecting the face (moon face), neck (buffalo hump), and abdomen, with relatively thin arms and legs Persistent hypertension that is difficult to control with standard medications Easy bruising or thin, fragile skin that heals poorly Purple or red stretch marks (striae) on the abdomen, thighs, or breasts Muscle weakness , particularly affecting the shoulders and hips Mood changes including depression, anxiety, or irritability that persist despite usual management Irregular menstrual periods or reduced libido Recurrent infections or poor wound healing New-onset diabetes or worsening glycaemic control in established diabetes Seek urgent medical attention if you develop signs of adrenal crisis, which can occur in patients with adrenal insufficiency (often after withdrawal of long-term steroids)
